Saturna Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $511M | Sell |
555,104
-6,242
| -1% | -$6.33M | 7.16% | 2 |
|
|
2025
Q4 | $603M | Sell |
561,346
-28,164
| -5% | -$26.9M | 8% | 2 |
|
|
2025
Q3 | $450M | Sell |
589,510
-4,074
| -0.7% | -$3.03M | 5.8% | 5 |
|
|
2025
Q2 | $463M | Sell |
593,584
-7,172
| -1% | -$5.57M | 6.25% | 3 |
|
|
2025
Q1 | $496M | Sell |
600,756
-28,326
| -5% | -$23.6M | 7.43% | 1 |
|
|
2024
Q4 | $486M | Sell |
629,082
-20,329
| -3% | -$16.8M | 6.59% | 2 |
|
|
2024
Q3 | $575M | Sell |
649,411
-33,487
| -5% | -$30.1M | 7.52% | 1 |
|
|
2024
Q2 | $618M | Sell |
682,898
-9,711
| -1% | -$7.77M | 8.21% | 1 |
|
|
2024
Q1 | $539M | Sell |
692,609
-18,697
| -3% | -$13.3M | 7.44% | 1 |
|
|
2023
Q4 | $415M | Sell |
711,306
-48,927
| -6% | -$28.6M | 6.46% | 2 |
|
|
2023
Q3 | $408M | Sell |
760,233
-35,435
| -4% | -$18.3M | 7.22% | 1 |
|
|
2023
Q2 | $373M | Sell |
795,668
-1,150
| -0.1% | -$482K | 6.45% | 2 |
|
|
2023
Q1 | $274M | Sell |
796,818
-18,125
| -2% | -$6.11M | 5.3% | 2 |
|
|
2022
Q4 | $298M | Sell |
814,943
-677
| -0.1% | -$240K | 6.41% | 1 |
|
|
2022
Q3 | $264M | Sell |
815,620
-15
| -0% | -$4.75K | 6.43% | 2 |
|
|
2022
Q2 | $264M | Sell |
815,635
-104,750
| -11% | -$31.4M | 6.26% | 2 |
|
|
2022
Q1 | $264M | Buy |
920,385
+50
| +0% | +$12.9K | 5.31% | 2 |
|
|
2021
Q4 | $245M | Buy |
920,335
+32
| +0% | +$8.11K | 4.39% | 5 |
|
|
2021
Q3 | $215M | Buy |
920,303
+515
| +0.1% | +$127K | 4.33% | 6 |
|
|
2021
Q2 | $211M | Hold |
919,788
| – | – | 4.33% | 6 |
|
|
2021
Q1 | $172M | Sell |
919,788
-1,360
| -0.1% | -$266K | 3.83% | 6 |
|
|
2020
Q4 | $156M | Buy |
921,148
+55
| +0% | +$8.21K | 3.51% | 6 |
|
|
2020
Q3 | $136M | Sell |
921,093
-15
| -0% | -$2.32K | 3.47% | 5 |
|
|
2020
Q2 | $151M | Hold |
921,108
| – | – | 4.24% | 3 |
|
|
2020
Q1 | $128M | Sell |
921,108
-60,000
| -6% | -$8.24M | 4.14% | 3 |
|
|
2019
Q4 | $129M | Hold |
981,108
| – | – | 3.49% | 3 |
|
|
2019
Q3 | $110M | Sell |
981,108
-210
| -0% | -$23.4K | 3.19% | 4 |
|
|
2019
Q2 | $109M | Buy |
981,318
+810
| +0.1% | +$95.4K | 3.19% | 4 |
|
|
2019
Q1 | $127M | Sell |
980,508
-4,492
| -0.5% | -$546K | 3.71% | 2 |
|
|
2018
Q4 | $114M | Hold |
985,000
| – | – | 3.84% | 1 |
|
|
2018
Q3 | $106M | Hold |
985,000
| – | – | 3.08% | 4 |
|
|
2018
Q2 | $84M | Sell |
985,000
-160,000
| -14% | -$13.1M | 2.69% | 4 |
|
|
2018
Q1 | $88.6M | Sell |
1,145,000
-100,000
| -8% | -$8.05M | 2.82% | 4 |
|
|
2017
Q4 | $105M | Buy |
1,245,000
+325
| +0% | +$27.7K | 3.22% | 2 |
|
|
2017
Q3 | $106M | Buy |
1,244,675
+375
| +0% | +$30.8K | 3.45% | 1 |
|
|
2017
Q2 | $102M | Hold |
1,244,300
| – | – | 3.4% | 1 |
|
|
2017
Q1 | $105M | Hold |
1,244,300
| – | – | 3.55% | 1 |
|
|
2016
Q4 | $91.5M | Sell |
1,244,300
-40,000
| -3% | -$2.98M | 3.21% | 1 |
|
|
2016
Q3 | $103M | Buy |
1,284,300
+50
| +0% | +$4K | 3.36% | 1 |
|
|
2016
Q2 | $101M | Buy |
1,284,250
+150
| +0% | +$11.3K | 3.24% | 1 |
|
|
2016
Q1 | $98.5M | Hold |
1,284,100
| – | – | 3.15% | 1 |
|
|
2015
Q4 | $108M | Buy |
1,284,100
+500
| +0% | +$41.5K | 3.34% | 1 |
|
|
2015
Q3 | $107M | Hold |
1,283,600
| – | – | 3.38% | 1 |
|
|
2015
Q2 | $107M | Sell |
1,283,600
-265
| -0% | -$20.2K | 3.01% | 1 |
|
|
2015
Q1 | $93.8M | Hold |
1,283,865
| – | – | 2.52% | 3 |
|
|
2014
Q4 | $88.6M | Hold |
1,283,865
| – | – | 2.32% | 7 |
|
|
2014
Q3 | $83.3M | Sell |
1,283,865
-1,000
| -0.1% | -$63.3K | 2.23% | 6 |
|
|
2014
Q2 | $79.9M | Hold |
1,284,865
| – | – | 2.08% | 6 |
|
|
2014
Q1 | $75.6M | Hold |
1,284,865
| – | – | 1.99% | 7 |
|
|
2013
Q4 | $65.5M | Sell |
1,284,865
-200
| -0% | -$10K | 1.67% | 8 |
|
|
2013
Q3 | $64.7M | Sell |
1,285,065
-500
| -0% | -$26.2K | 1.72% | 10 |
|
|
2013
Q2 | $63.1M | Buy |
+1,285,565
| New | +$70M | 1.73% | 9 |
|
Other funds holding LLY
VCM
VPM
Saturna Capital's LLY Position: Q1 2026 in Review
Saturna Capital reduced its Eli Lilly (LLY) stake by 1.1% in Q1 2026, selling an estimated $6.33M and leaving 555,104 shares worth $511M. The position accounts for 7.16% of the portfolio, ranked #2.
Saturna Capital first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $618M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Saturna Capital held 555,104 shares of Eli Lilly worth $511M as of Q1 2026.
- Saturna Capital sold 6,242 Eli Lilly shares in Q1 2026, an estimated $6.33M.
- Eli Lilly made up 7.16% of Saturna Capital's portfolio in Q1 2026, its #2 holding.
- Saturna Capital first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Saturna Capital's Eli Lilly position peaked at $618M in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Saturna Capital's 13F filing for Q1 2026, filed 12 May 2026.